Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer - Concepedia

Concepedia

Publication | Closed Access

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

658

Citations

24

References

2009

Year

José Baselga, Peter van Dam, Alexey Manikhas, Meritxell Bellet, José Mayordomo, Mario Campone, E. Kubista, Richard Greil, Giulia Bianchi, Jutta Steinseifer,

Journal of Clinical Oncology

Abstract

Everolimus significantly increased letrozole efficacy in neoadjuvant therapy of patients with ER-positive breast cancer.

References

	Year	Citations

Page 1